Edition:
United States

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,565JPY
26 Apr 2017
Change (% chg)

-- (--)
Prev Close
¥1,565
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,190,740
52-wk High
¥1,779
52-wk Low
¥1,415

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 29.84 March 26 Apr 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 2 2
(2) OUTPERFORM 3 3 3 5
(3) HOLD 7 7 6 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.55 2.55 2.36 2.18

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 1 337,200.00 337,200.00 337,200.00 --
Quarter Ending Dec-17 1 387,000.00 387,000.00 387,000.00 --
Year Ending Mar-17 10 1,316,810.00 1,335,000.00 1,295,000.00 1,442,580.00
Year Ending Mar-18 11 1,370,870.00 1,450,000.00 1,347,000.00 1,501,040.00
Earnings (per share)
Quarter Ending Sep-17 1 29.84 29.84 29.84 --
Quarter Ending Dec-17 1 35.09 35.09 35.09 --
Year Ending Mar-17 11 98.77 104.07 94.81 94.50
Year Ending Mar-18 12 101.14 108.25 92.85 102.78
LT Growth Rate (%) 1 3.92 3.92 3.92 19.53

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-16 352,821.00 353,914.00 1,093.34 0.31
Quarter Ending Sep-16 319,377.00 313,921.00 5,455.66 1.71
Quarter Ending Jun-16 322,117.00 337,752.00 15,635.34 4.85
Quarter Ending Mar-16 314,167.00 307,040.00 7,127.00 2.27
Quarter Ending Dec-15 373,075.00 378,165.00 5,090.00 1.36

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 337,200.00 346,000.00 346,000.00 346,000.00 --
Quarter Ending Dec-17 387,000.00 397,000.00 397,000.00 397,000.00 --
Year Ending Mar-17 1,316,810.00 1,316,800.00 1,321,570.00 1,319,250.00 1,442,580.00
Year Ending Mar-18 1,370,870.00 1,374,100.00 1,376,960.00 1,377,000.00 1,501,040.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 1 0 1
Quarter Ending Dec-17 0 1 0 1
Year Ending Mar-17 1 0 1 1
Year Ending Mar-18 0 1 0 3
Earnings

More From Around the Web